Advanced Glycation End Products (AGEs) Webinar Meeting Report

Cindy N. Ho; Alessandra T. Ayers; Paul Beisswenger; Stuart Chalew; Ann Marie Schmidt; Ambarish Pandey; Pankaj Kapahi; Alexander Fleming; David C. Klonoff

doi:10.1177/19322968241296541

Advanced Glycation End Products (AGEs) Webinar Meeting Report

Cindy N. Ho, Alessandra T. Ayers, Paul Beisswenger, Stuart Chalew, Ann Marie Schmidt, Ambarish Pandey, Pankaj Kapahi, Alexander Fleming, David C. Klonoff

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and the glycation gap (GG), (3) formation and structure of AGEs, (4) AGEs as a risk factor of cardiovascular disease (CVD), and (5) approaches to limit or prevent AGE formation.

Original language	English (US)
Pages (from-to)	576-581
Number of pages	6
Journal	Journal of Diabetes Science and Technology
Volume	19
Issue number	2
DOIs	https://doi.org/10.1177/19322968241296541
State	Published - Mar 2025
Externally published	Yes

Keywords

AGE formation
AGE prevention
advanced glycation end products
aging
chronic diseases

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Bioengineering
Biomedical Engineering

Access to Document

10.1177/19322968241296541

Cite this

@article{2d7b140a56304c9a9934d2ab38f6a09b,

title = "Advanced Glycation End Products (AGEs) Webinar Meeting Report",

abstract = "The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and the glycation gap (GG), (3) formation and structure of AGEs, (4) AGEs as a risk factor of cardiovascular disease (CVD), and (5) approaches to limit or prevent AGE formation.",

keywords = "AGE formation, AGE prevention, advanced glycation end products, aging, chronic diseases",

author = "Ho, {Cindy N.} and Ayers, {Alessandra T.} and Paul Beisswenger and Stuart Chalew and Schmidt, {Ann Marie} and Ambarish Pandey and Pankaj Kapahi and Alexander Fleming and Klonoff, {David C.}",

note = "Publisher Copyright: {\textcopyright} 2024 Diabetes Technology Society.",

year = "2025",

month = mar,

doi = "10.1177/19322968241296541",

language = "English (US)",

volume = "19",

pages = "576--581",

journal = "Journal of Diabetes Science and Technology",

issn = "1932-2968",

publisher = "SAGE Publications Inc.",

number = "2",

}

TY - JOUR

T1 - Advanced Glycation End Products (AGEs) Webinar Meeting Report

AU - Ho, Cindy N.

AU - Ayers, Alessandra T.

AU - Beisswenger, Paul

AU - Chalew, Stuart

AU - Schmidt, Ann Marie

AU - Pandey, Ambarish

AU - Kapahi, Pankaj

AU - Fleming, Alexander

AU - Klonoff, David C.

PY - 2025/3

Y1 - 2025/3

N2 - The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and the glycation gap (GG), (3) formation and structure of AGEs, (4) AGEs as a risk factor of cardiovascular disease (CVD), and (5) approaches to limit or prevent AGE formation.

AB - The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and the glycation gap (GG), (3) formation and structure of AGEs, (4) AGEs as a risk factor of cardiovascular disease (CVD), and (5) approaches to limit or prevent AGE formation.

KW - AGE formation

KW - AGE prevention

KW - advanced glycation end products

KW - aging

KW - chronic diseases

UR - http://www.scopus.com/inward/record.url?scp=85209180039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85209180039&partnerID=8YFLogxK

U2 - 10.1177/19322968241296541

DO - 10.1177/19322968241296541

M3 - Article

C2 - 39508279

AN - SCOPUS:85209180039

SN - 1932-2968

VL - 19

SP - 576

EP - 581

JO - Journal of Diabetes Science and Technology

JF - Journal of Diabetes Science and Technology

IS - 2

ER -

Advanced Glycation End Products (AGEs) Webinar Meeting Report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this